Page 5 - Jeff Albers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff albers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Albers Today - Breaking & Trending Today

Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results


Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results
Supplemental NDA accepted by FDA for AYVAKIT™ (avapritinib) for advanced systemic mastocytosis
Type II variation MAA submitted to EMA for AYVAKYT® (avapritinib) for advanced systemic mastocytosis
Announced a potential best-in-class research program targeting CDK2 for the treatment of multiple cancers with tumor-associated cell cycle defects
Plan to provide updates across multiple clinical and research programs at AACR 2021 Annual Meeting
Ended 2020 with approximately $1.5 billion in cash
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., Feb. 17, 2021 /PRNewswire/ Blueprint Medicines Corporation (NASDAQ:BPMC) today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2020. ....

United States , United Kingdom , Jeff Albers , Becker Hewes , Blueprint Medicines Corporation , European Commission , Drug Administration , Genentech Inc , American Society Of Hematology , Exchange Commission , Research Portfolio , Health Care Conference On , Prnewswire Blueprint Medicines Corporation , European Medicines Agency , Roche Group , Medicines Corporation , Blueprint Medicines , Chief Executive Officer , Prescription Drug User Fee , American Society , Annual Meeting , Chief Medical Officer , Year End , Blueprint Medicine , Blueprint Medicine January , Global Healthcare Conference ,